Carl L. Gordon, Director, 10% Owner at Terns Pharmaceuticals, Inc. (TERN), bought 275,862 shares at $7.25 ($2.0M) on 2022-12-23, disclosed to the SEC on 2022-12-28.
Open-market purchase of $2.0M TERN by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.25 | 137,931 | $1000K | 50.0% |
| 2 | $7.25 | 137,931 | $1.0M | 50.0% |
| Total | $7.25 avg | 275,862 | $2.0M | 100% |
| Filing → |
| SCTX | BUY | 2026-07-29 | $15.0M | — | Filing → |
| CMPX | SELL | 2025-04-11 | $11.4M | — | Filing → |
| MBX | BUY | 2025-02-19 | $2.7M | — | Filing → |